30
Views
3
CrossRef citations to date
0
Altmetric
Review

Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib

Pages 1521-1538 | Published online: 22 Feb 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.